Immunic, Inc. is trading at $14.97 (+5.65%) on no clear company-specific catalyst following a strong early-session move.
- No major clinical updates, regulatory events, or corporate announcements have been identified to explain the current price action.
- The advance appears to be driven by momentum and recent volatility rather than fresh fundamental news.
- Broader market conditions remain mixed as the stock continues its price-driven move.